Heart Failure Hospitalization (HFH) Despite Digoxin Therapy Versus No HFH Despite Placebo in the Digitalis Investigation Group (DIG) Trial: Insights Into Risk Factors for HFH in hf and Reduced Ejection Fraction (HFrEF)
Document Type
Abstract
Publication Date
March 2017
Journal Title
Journal of the American College of Cardiology
Department
Medicine
Recommended Citation
Bhyan, P., Tsimploulis, A., Dooley, D., Lam, P., Arundel, C., Deedwania, P., Fonarow, G., Butler, J., White, M., Wu, W., Aronow, W. S., Kanonidis, I., Morgan, C., Pitt, B., Blackman, M., Bhatt, D., & Ahmed, A. (2017). Heart Failure Hospitalization (HFH) Despite Digoxin Therapy Versus No HFH Despite Placebo in the Digitalis Investigation Group (DIG) Trial: Insights Into Risk Factors for HFH in hf and Reduced Ejection Fraction (HFrEF). Journal of the American College of Cardiology, 69 (11 Suppl.), 911. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/13
COinS
